You have 0 free disease views remaining today. Register for more view, it is 100% free →
autosomal recessive intellectual developmental disorder 39
Description
Autosomal Recessive Intellectual Developmental Disorder 39 (MRT39) is a condition characterized by below-average intellectual functioning, adaptive behavior, and various degrees of physical and sensory impairments [1]. It is caused by mutations in the TTI2 gene on chromosome 8p12 [5][9].
The symptoms of MRT39 can vary widely among affected individuals, but may include:
- Global developmental delay
- Intellectual disability
- Adaptive behavior impairments
- Physical and sensory impairments
MRT39 is a rare condition, and its exact prevalence is unknown. However, it is considered to be an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to express the condition [2][7].
It's worth noting that MRT39 is distinct from Autosomal Dominant Intellectual Developmental Disorder 39 (MRD39), which is caused by mutations in the MYT1L gene and has a different set of symptoms [3][8].
Additional Characteristics
- Global developmental delay
- Intellectual disability
- Adaptive behavior impairments
- Physical and sensory impairments
Signs and Symptoms
Based on the available information, here are the signs and symptoms associated with Autosomal Recessive Intellectual Developmental Disorder 39 (MRT39):
- Impaired intellectual development: This condition is characterized by impaired intellectual development, which can manifest as delayed or absent speech, poor sleep, and other cognitive difficulties [1].
- Global developmental delay: Some patients with MRT39 may experience global developmental delay, which can affect various aspects of development, including motor skills, language, and social interactions [3].
- Macrocephaly: Macrocephaly, or an abnormally large head size, has been reported in some cases of MRT39 [3].
- Seizures: Seizures have also been observed in patients with this condition [3].
It's worth noting that the severity and specific symptoms of MRT39 can vary widely among affected individuals. If you're looking for more detailed information or would like to know about other aspects of this condition, please let me know!
References: [1] - Context result 2 [3] - Context result 3
Additional Symptoms
- Global developmental delay
- Macrocephaly
- Seizures
- Impaired intellectual development
Diagnostic Tests
Based on the provided context, here are some diagnostic tests that may be relevant for autosomal recessive intellectual developmental disorder 74:
- Chromosomal microarray analysis: This is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies [3].
- Genetic testing: Genetic testing can help identify the underlying cause of the condition, and may involve testing genes such as ST3GAL3 (1p34.1) [2].
- Karyotype analysis: G-banded karyotyping has historically been used to detect genetic imbalance in patients with intellectual developmental disorders [7].
- Metabolic testing: Metabolic testing may be performed to rule out other conditions that can cause intellectual disability.
- Testing for fragile X syndrome: Fragile X syndrome is a genetic condition that can cause intellectual disability, and testing for this condition may be recommended if there are specific clinical features present.
It's worth noting that the diagnostic approach may vary depending on individual circumstances, and a comprehensive evaluation by a qualified healthcare professional is necessary to determine the best course of action.
Additional Diagnostic Tests
- Metabolic testing
- Genetic testing
- Karyotype analysis
- Chromosomal microarray analysis
- Testing for fragile X syndrome
Treatment
Based on the provided context, it appears that there is limited information available on the specific drug treatment for autosomal recessive intellectual developmental disorder 39 (MRT39). However, I can provide some general information on the topic.
Current Understanding
Autosomal recessive intellectual developmental disorders are a group of genetic conditions characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior. While there is no specific treatment for MRT39, research suggests that certain therapies and interventions may be beneficial in managing symptoms and improving quality of life.
- Therapy: Early intervention and therapy, such as occupational, physical, and speech therapy, can help improve cognitive and motor skills (1).
- Medications: In some cases, medications may be prescribed to manage associated symptoms like seizures or behavioral issues. However, there is no specific medication mentioned in the context for MRT39.
Research Gaps
It's essential to note that more research is needed to understand the underlying causes and optimal treatment strategies for autosomal recessive intellectual developmental disorders, including MRT39.
- Limited information: The provided context does not mention any specific drug treatment or therapy for MRT39 (1-5).
- Need for further research: More studies are required to identify effective treatments and management strategies for individuals with MRT39 and similar conditions (6-10).
Recommendations
If you're looking for information on the drug treatment of autosomal recessive intellectual developmental disorder 39, I recommend consulting a healthcare professional or a genetic counselor. They can provide personalized guidance and recommendations based on the latest research and your individual situation.
References:
(1) Context result 2 (3) Context result 5 (6) Context result 10
Recommended Medications
- Physical therapy
- Occupational therapy
- Speech therapy
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
The differential diagnosis for autosomal recessive intellectual developmental disorder (ARID) involves considering various genetic conditions that can present with similar symptoms.
According to the search results, ARID contributes to about 10% of cases in an outbred population [3]. The syndrome has a wide range of differential diagnoses, including:
- Angelman syndrome: A neurogenetic disorder characterized by severe intellectual and developmental disabilities [6]
- Coffin-Siris syndrome: A rare genetic disorder that affects physical and intellectual development [7]
- Intellectual disability-sparse hair-brachydactyly syndrome: A condition characterized by intellectual disability, sparse hair, and short fingers [7]
- Zimmermann-Laband syndrome: A rare genetic disorder that affects physical and intellectual development [7]
Additionally, the differential diagnosis for ARID may also include other conditions such as:
- Autosomal dominant intellectual developmental disorders
- Nonsyndromic X-linked intellectual developmental disorders
- Syndromic X-linked intellectual developmental disorders
It's worth noting that a specific genetic diagnosis can be made by identifying pathogenic variants in genes associated with intellectual disability, and determining the respective inheritance pattern [14]. This information can help guide counseling and reproductive testing options.
References:
[3] R Jamra · 2018 · Cited by 57 [6] Dec 19, 2023 [7] Differential diagnoses include Coffin-Siris syndrome, intellectual disability-sparse hair-brachydactyly syndrome, Zimmermann-Laband syndrome, fetal alcohol ... [14] On the other hand, autosomal dominant, autosomal recessive, and X-linked disorders are associated with substantially higher recurrence risks.
Additional Differential Diagnoses
- Intellectual disability-sparse hair-brachydactyly syndrome
- Autosomal dominant intellectual developmental disorders
- Nonsyndromic X-linked intellectual developmental disorders
- Syndromic X-linked intellectual developmental disorders
- N syndrome
- Coffin-Siris syndrome 1
- Angelman syndrome
Additional Information
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0081204
- core#notation
- DOID:0081204
- oboInOwl#hasDbXref
- MIM:615541
- IAO_0000115
- An autosomal recessive intellectual developmental disorder that has_material_basis_in homozygous mutation in the TTI2 gene on chromosome 8p12.
- rdf-schema#label
- autosomal recessive intellectual developmental disorder 39
- rdf-schema#subClassOf
- http://purl.obolibrary.org/obo/DOID_0060308
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_4030
- owl#annotatedSource
- t361460
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.